Minimum inhibitory concentrations of herbal essential oils and monolaurin for gram-positive and gram-negative bacteria

Molecular and Cellular Biochemistry

Volumn 272, Issue 1-2, 2005, Pages 29-34

  Preuss, Harry G ^a   Echard, Bobby ^a   Enig, Mary ^b   Brook, Itzhak ^c   Elliott, Thomas B ^c  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b Enig Associates Inc   (United States)

^c ARMED FORCES RADIOBIOLOGY RESEARCH INSTITUTE   (United States)

Author keywords

Antibacterial effect; Essential oils; Monolaurin; Oregano oil

Indexed keywords

ACYLGLYCEROL LIPASE; AMOXICILLIN; ANTIINFECTIVE AGENT; BAY LEAF OIL; CASSIA OIL; CUMIN OIL; ESSENTIAL OIL; EUCALYPTUS OIL; HERBACEOUS AGENT; LAVENDER OIL; MYRTLE OIL; OLIVE OIL; OREGANO OIL; P73 OREGANOL; PENICILLIN G; PUMPKIN SEED OIL; SAGE OIL; STREPTOMYCIN; UNCLASSIFIED DRUG; VANCOMYCIN; VEGETABLE OIL;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL INFECTION; BACTERICIDAL ACTIVITY; BACTERIOSTASIS; CONTROLLED STUDY; CUMIN; DISEASE SEVERITY; DRUG SAFETY; DRUG SYNTHESIS; ESCHERICHIA COLI; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HELICOBACTER PYLORI; HERBAL MEDICINE; IN VITRO STUDY; KLEBSIELLA PNEUMONIAE; MINIMUM INHIBITORY CONCENTRATION; MYCOBACTERIUM TERRAE; MYRTLE; NONHUMAN; OREGANO; PUMPKIN; SENNA; SPICE; STAPHYLOCOCCUS AUREUS;

ANTI-BACTERIAL AGENTS; GLYCERIDES; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; LAURATES; MICROBIAL SENSITIVITY TESTS; MONOGLYCERIDES; OILS, VOLATILE; ORIGANUM; PLANT OILS;

BACILLUS ANTHRACIS STR. STERNE; ESCHERICHIA COLI; HELICOBACTER PYLORI; KLEBSIELLA PNEUMONIAE; MYCOBACTERIUM TERRAE; NEGIBACTERIA; ORIGANUM; ORIGANUM VULGARE; POSIBACTERIA; STAPHYLOCOCCUS AUREUS;

EID: 20944445355     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11010-005-6604-1     Document Type: Article

References (42)

1. U.S. Congress 1995 Office of Technology Assessment: Impacts of antibiotic resistant bacteria OTA-H-629 U.S. Government Printing Office Washington DC
2. Ayliffe GA: The progressive intercontinental spreads of methicillin-resistant Staphylococcus aureus. Clin Infect Dis 24(Suppl 1): S74-S79, 1997 8994782
3. Cunha BA: Strategies to control antibiotic resistance. Sem Resp Infect 17: 250-258, 2002 10.1053/srin.2002.34692
4. Edmond MB, Wenzel RP, Pasculle AW: Vancomycin-resistant Staphylococcus aureus: Perspectives on measures needed for control. Ann Intern Med 124: 329-334, 1996 1:STN:280:BymC2cfmsVY%3D
5. Waldvogel WW: New resistance in Staphylococcus aureus. N Eng J Med 340: 556-557, 1999 10.1056/NEJM199902183400709
6. Burnie J, Matthews R, Jiman-Fatami A, Gottardello P, Hodgetts S, D'arcy S: Analysis of 42 cases of septicemia caused by an epidemic strain of methicillin-resistant Staphylococcus aureus: Evidence of resistance to vancomycin. Clin Infect Dis 31: 684-689, 2000 10.1086/314035
7. Hiramatsu K, Hanake H, Ino T, Yabuta K, Oguri T, Tenover FC: Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 40: 135-136, 1997 10.1093/jac/40.1.135
8. Sieradzki K, Roberts RB, Haber SW, Tomasz A: The development of vancomycin resistance in a patient with methicillin-resistant Staphylococcus infection. N Eng J Med 340: 517-523, 1999 10.1056/ NEJM199902183400704
9. Denis O, Nonhoff C, Byl B Knoop C, Bobin-Dubreux S, Struelens MJ: Emergence of vancomycin-intermediate Staphylococcus aureus in a Belgian hospital: Microbiological and clinical features. J Antimicrob Chemother 50: 383-391, 2002 10.1093/jac/dkf142
10. Brook I, Elliott TB, Pryor HI, Sautter TE, Gnade BT, Thakar JH, Knudson GB. In vitro resistance of Bacillus anthracis Sterne to doxocycline, macrolides and quinolones. Intern J Antimicrob Agents 18: 559-562, 2001 10.1016/S0924-8579(01)00464-2
11. Brook I, Elliott TB, Harding RA, Bouhaouala SS, Peacock SJ, Ledney GD, Knudson GB: Susceptibility of irradiated mice to Bacillus anthracis Sterne by the intratracheal route of infection. J Med Microbiol 50: 702-711, 2001 1:STN:280:DC%2BD3MvjtFaisw%3D%3D
12. Choe CH, Bouhaouala SS, Brook I, Elliott TB, Knudson GB: In vitro development of resistance to ofloxacin and doxycycline in Bacillus anthracis Sterne. Antimicrob Agents Chemother 44: 1766, 2000 10.1128/AAC.44.6.1766-1766.2000
13. Pile JC, Malone JD, Eitzen EM, Friedlander AM: Anthrax as a potential biological warfare agent. Arch Intern Med 158: 429-434, 1998 10.1001/ archinte.158.5.429
14. Horsburgh Jr CR, Felman S, Ridzon R: Practice guidelines for the treatment of tuberculosis. Clin Infect Dis 31: 633-639, 2000 10.1086/ 314007
15. Remis RS, Jamieson F, Chedore P, Haddad A, Vernich L: Increasing drug resistance of Mycobacterium tuberculosis isolates in Ontario, Canada, 1987-1998. Clin Infect Dis 31: 427-432, 1998 10.1086/313969
16. Manohar V, Ingram C, Gray J, Talpur N, Echard BW, Bagchi D, Preuss HG: Antifungal activities of origanum oil against Candida albicans. Mol Cell Biochem 228: 111-117, 2001 10.1023/A:1013311632207
17. Manohar V, Ingram C, Gray J, Talpur N, Echard BW, Preuss HG: Antibacterial effects of the edible oil of oregano against Staphlococcus aureus. J Am Coll Nutr 20: 66, 2001 (abstract)
18. Griffiths PA, Babb JR, Fraise AP: Mycobacterium terrae: A potential surrogate for Mycobacterium tuberculosis in a standard disinfectant test. J Hosp Infect 38: 183-192, 1998 10.1016/S0195-6701(98)90273-0
19. Kim J, Marshall MR, Wei, C-I: Antibacterial activity of some essential oil components against five foodborne pathogens. J Agric Food Chem 43: 2839-2845, 1995 10.1021/jf00059a013
20. Carson CF, Cookson BD, Farrelly HD, Riley TV: Susceptibility of methicillin resistant Staphylococcus aureus to the essential oil of Melaleuca alternifolia. J Antimicrob Chemother 35: 421-424, 1995 1:CAS:528:DyaK2MXks12hu7g%3D
21. MA Schmidt KW Sehnert LH Smith 1994 Beyond Antibiotics. 50 (Or So) Ways to Boost Immunity and Avoid Antibiotics North Atlantic Books Berkeley, CA
22. Ismaiel A, Pierson MD: Inhibition of growth and germination of C botulinum 33A, 40B, and 1623E by essential oil of spices. J Food Sci 55: 1676-1680, 1990
23. Mansour M, Bouttefroy AD, Linder M, Milliere JB: Inhibition of Bacillus licheniformis spore growth in milk by nisin, monolaurin and pH combinations. J Appl Microbiol 86: 311-324, 1999 10.1046/ j.1365-2672.1999.00669.x
24. Kivanc M, Akgul A, Dogan A: Inhibitory and stimulatory effects of cumin, oregano and their essential oils on growth and acid production of Lactobacillus plantarum and Leuconostoc mesenteroides. Intern J Food Microbiol 13: 81-86, 1991 10.1016/0168-1605(91)90140-K
25. Hammer KA, Carson CF, Riley TV: Antimicrobial activity of essential oils and other plant extracts. J Appl Microbiol 86: 985-990, 1999 10.1046/ j.1365-2672.1999.00780.x
26. Tucker AO, Maciarello MJ: Oregano: Botany, chemistry, and cultivation. In: G. Charalambus (ed). Spices, Herbs, and Edible Fungi, Elsevier Science, St Louis, MO, 1994, pp 439-456
27. Sivropoulus A, Papanikolaou E, Nikolaou C, Kokkini S, Lanaras T, Arsenakis M: Antimicrobial and cytoxic activities of origanum essential oils. J Agric Food Chem 44: 1202-1205, 1996 10.1021/jf950540t
28. Siddiqui YM, Ettayebi M, Haddad A, Al-Ahdal MN: Effect of essential oils on enveloped viruses: Antiviral activity of oregano and clove oils on Herpes simplex virus type 1 and Newcastle disease virus. Medi Sci Res 24: 185-186, 1996 1:CAS:528:DyaK28Xjt1Wlsrc%3D
29. MG Enig 1998 Lauric oils as antimicrobial agents: Theory of effect, scientific rationale, and dietary application as adjunct nutritional support for HIV-infected individuals R.R. Watson Nutrients and Foods in AI12/3/04 CRC Press Boca Raton, FL 81-97
30. Kabara JJ: Lipids as host-resistance factors of human milk. Nutr Rev 38: 65-73, 1980 1:CAS:528:DyaL3cXkt1Cjtb8%3D
31. Kabara JJ, Vrable R: Antimicrobial lipids: Natural and synthetic acids and monoglycerides. Lipids 12: 753-759, 1977 1:CAS:528:DyaE1cXksFGlsw%3D%3D
32. Conley AJ, Kabara JJ: Antimicrobial action of esters of polyhydric alcohols. Antimicrob Agents Chemother 4: 501-506, 1973 1:CAS:528:DyaE2cXksVaqsg%3D%3D
33. Schlievert PM, Deringer JR, Kim MH, Projan SJ, Novick RP: Effect of glycerol monolaurate on bacterial growth and toxin production. Antimicrob Agents Chemother 36: 626-631, 1992 1:CAS:528:DyaK38XhvVWisrg%3D
34. Projan SJ, Brown-Skrobot S, Schlievert PM: Glycerol monolaurate inhibits the production of B-lactamase, toxic shock syndrome toxin-1, and other staphylococcal exoproteins by interfering with signal transduction. J Bacteriol 176: 4204-4209, 1994 1:CAS:528:DyaK2cXkslyitrw%3D
35. Ruzin A, Novick RP: Glycerol monolaurate as inhibitors of signal transduction in Staphylococcus aureus. J Bacteriol 182: 2668-2671, 2000 10.1128/JB.182.9.2668-2671.2000
36. Ruzin A, Novick RP: Glycerol monolaurate inhibits induction of vancomycin resistance in Enterococcus faecalis. J Bacteriol 180.: 182-185, 1998 1:CAS:528:DyaK1cXotVah
37. Bergsson G, Arnfinnsson J, Karlsson SM, Steingrimsson O, Thormar H: In vitro inactivation of Chlamydia trachomatis by fatty acids and monoglycerides. Antimicrob Agents Chemother 42: 2290-2294, 1998 1:CAS:528:DyaK1cXmtVWqsLg%3D
38. Thormar H, Isaacs CE, Brown HR, Barshatzky MR, Pessolano T: Inactivation of enveloped viruses and killing of cells by fatty acids and monoglycerides. Antimicrob Agents Chemother 31: 27-31, 1987 1:CAS:528:DyaL2sXhtlWhtbk%3D
39. Isaacs CE, Kashyap S, Heird WC, Thormar H: Anitiviral and antibacterial lipids in human milk and infant formula feed. Arch Dis Childhood 65: 272-273, 1991
40. Isaacs CE, Thormar H: The role of milk-derived antimicrobial lipids as antiviral and antibacterial agents. Adv Exper Med Biol 310: 159-165, 1991 1:CAS:528:DyaK3sXhsVGju78%3D
41. Petschow BW, Batema RP, Ford LL: Susceptibility of Helicobacter pylori to bactericidal properties of medium-chain monoglycerides and free fatty acids. Antimicrob Agents Chemother 40: 302-306, 1996 1:CAS:528:DyaK28Xos1Wmsg%3D%3D
42. CDC: Helicobacter pylori and peptic ulcer disease. http://www.cdc.gov/ulcer/md.htm (entered May 12, 2003)